Thursday, October 30, 2014

VAL-083 drug compound shows promise against non-small cell lung cancer

›
We know that, VAL-083 is a bi-functional alkylating agent; inhibit U251 and SF188 cell growth in monolayer better than TMZ and caused ...
Wednesday, October 29, 2014

Synthetic oil triheptanoin improves Rett syndrome, longevity

›
We know that,  Triheptanoin  is a  triglyceride  that is composed of three seven-carbon  fatty acids . These odd-carbon fatty acids are ab...
Tuesday, October 28, 2014

Akynzeo Approved for Side Effects of Chemotherapy

›
The combination drug Akynzeo [ netupitant (left) and palonosetron  (right)] has been approved by the U.S. Food and Drug Administration to ...
Monday, October 27, 2014

Harvoni Approved for Chronic Hepatitis C

›
In continuation of my update on    ledipasvir and sofosbuvir  (Harvoni- combination pill)  Harvoni, a daily pill that treats the most co...
Friday, October 24, 2014

Impotence Drug Might Counter Common Gene Mutation in Type 2 Diabetes

›
In a small study, Swedish researchers found that the impotence drug yohimbine might help people with type 2 diabetes who have a particular...
Wednesday, October 22, 2014

FDA Approves Uceris (budesonide) Rectal Foam for Ulcerative Colitis

›
In continuation of my update on  budesonide Salix Pharmaceuticals, Ltd. announced that the Food and Drug Administration (FDA) has gran...
Tuesday, October 21, 2014

Attacking type 2 diabetes from a new direction with encouraging results

›
Type 2 diabetes affects  an estimated   28  million  Americans  according  to  the  American  Diabetes association, but medications ...
Monday, October 20, 2014

First pictures of BRCA2 protein show how it works to repair DNA

›
In continuation of my update on  BRCA2  Scientists have taken pictures of the BRCA2 protein for the first time, showing how it w...
Friday, October 17, 2014

'Programmable' antibiotic harnesses an enzyme to attack drug-resistant microbes

›
Rockefeller University researchers colonized mouse skin with a mix of bacterial cells, some resistant to the antibiotic kanamycin. ...
Thursday, October 16, 2014

Omega-3 fatty acids may prevent some forms of depression

›
Omega-3 fatty acids may prevent some forms of depression 
Wednesday, October 15, 2014

FDA Approves New Obesity Drug Contrave

›
In continuation of my update on  Contrave The U.S. Food and Drug Administration's approval of a new weight-loss drug on Wednesday ma...
Monday, October 13, 2014

Anamorelin drug safe and well tolerated in advanced non-small cell lung cancer, Phase III trial reveals

›
A new drug, anamorelin, improves appetite and body mass in patients with advanced lung cancer who are suffering cancer anorexia and cachex...

Oral afatinib significantly improves progression-free survival in patients with head and neck cancer

›
The tyrosine kinase inhibitor afatinib significantly improved progression-free survival compared to methotrexate in patients with recurre...
Sunday, October 12, 2014

Isavuconazole demonstrates successful outcomes in treatment of mucormycosis

›
In continuation of my update on  Isavuconazole Isavuconazole demonstrates successful outcomes in treatment of mucormycosis
Friday, October 10, 2014

Phase III trial: Rolapitant lessens chemotherapy-induced nausea and vomiting

›
Rolapitant reduces nausea and vomiting in patients receiving cisplatin-based chemotherapy, according to the results of a phase III trial p...